Phosphoric Acid

Phosphoric Acid

SCHEMBL4743957

CC(=O)O.CC(=O)O.CC(=O)O.O=P([O-])([O-])[O-].[Na+].[Na+].[Na+]

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.54
LCK P06239 1/20 0.54
FYN P06241 1/20 0.54
LMNA P02545 3/20 0.47
CA1 P00915 4/20 0.47
CA4 P22748 4/20 0.41
CA5A P35218 2/20 0.38
CA5B Q9Y2D0 2/20 0.38
SLC34A1 Q06495 1/20 0.38
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
KDM4E B2RXH2 1/20 0.33
CYP2C19 P33261 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL540831 1.00 FFAR3 (0.54) FFAR3LCKFYNLMNACA1
Phosphoric Acid SCHEMBL28271586 0.96 FFAR3 (0.50) FFAR3LCKFYNLMNACA1
Phosphoric Acid SCHEMBL3001932 0.92 FFAR3 (0.54) FFAR3LCKFYNLMNACA1
Phosphoric Acid SCHEMBL11339920 0.92 FFAR3 (0.54) FFAR3LCKFYNLMNACA1
Phosphoric Acid SCHEMBL2467383 0.92 FFAR3 (0.54) FFAR3LCKFYNLMNACA1
Phosphoric Acid SCHEMBL28282273 0.92 FFAR3 (0.54) FFAR3LCKFYNLMNACA1
Phosphoric Acid SCHEMBL28402400 0.92 FFAR3 (0.54) FFAR3LCKFYNLMNACA1
Phosphoric Acid SCHEMBL27606778 0.92 FFAR3 (0.54) FFAR3LCKFYNLMNACA1
Phosphoric Acid SCHEMBL16432302 0.90 LMNA (0.47) FFAR3LCKFYNLMNACA1
Phosphoric Acid SCHEMBL4743959 0.89 SLC34A1 (0.53) FFAR3LCKFYNLMNACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2691411-B1 BUFFER SYSTEM FOR PROTEIN PURIFICATION GLAXOSMITHKLINE LLC (US) 2020-02-26 EP disclosed
CN-106432648-B A kind of environment-friendly preparation method thereof of vinyl chloride/N, N- dimethacrylamide copolymer 宁波大学 2018-10-23 CN disclosed
CN-107915769-A Buffer solution system for protein purification 葛兰素史密斯克莱有限责任公司 2018-04-17 CN disclosed
US-9902837-B2 Oil extended functionalized styrene-butadiene copolymer ARLANXEO DEUTSCHLAND GMBH (DE) 2018-02-27 US disclosed
US-9868761-B2 Buffer system for protein purification GLAXOSMITHKLINE LLC (US) 2018-01-16 US disclosed
CN-105121476-B Oil extended functionalized styrene-butadiene copolymers 阿朗新科德国有限责任公司 2018-01-02 CN disclosed
EP-2986647-B1 OIL EXTENDED FUNCTIONALIZED STYRENE-BUTADIENE COPOLYMER ARLANXEO DEUTSCHLAND GMBH (DE) 2017-07-26 EP disclosed
US-20170174721-A1 BUFFER SYSTEM FOR PROTEIN PURIFICATION GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2017-06-22 US disclosed
US-9624261-B2 Buffer system for protein purification GLAXOSMITHKLINE LLC (US) 2017-04-18 US disclosed
CN-106432648-A Green preparation method of vinyl chloride-N,N-dimethyl acrylamide copolymer 宁波大学 2017-02-22 CN disclosed
EP-2792689-A1 Oil extended functionalized styrene-butadiene copolymer LANXESS Deutschland GmbH (DE) 2014-10-22 EP disclosed
EP-2691411-A1 BUFFER SYSTEM FOR PROTEIN PURIFICATION GlaxoSmithKline LLC (US) 2014-02-05 EP disclosed
CN-103547589-A Buffer system for protein purification GLAXOSMITHKLINE LLC 2014-01-29 CN disclosed
US-20140018525-A1 BUFFER SYSTEM FOR PROTEIN PURIFICATION GLAXOSMITHKLINE LLC (US) 2014-01-16 US disclosed
WO-2012135415-A1 BUFFER SYSTEM FOR PROTEIN PURIFICATION GLAXOSMITHKLINE LLC (US) 2012-10-04 WO disclosed
WO-2008112156-A1 CHEMOKINE RECEPTOR MODULATORS ALTIRIS THERAPEUTICS (US) 2008-09-18 WO disclosed
WO-2008109154-A1 CHEMOKINE RECEPTOR MODULATORS ALTIRIS THERAPEUTICS, INC. (US) 2008-09-12 WO disclosed
US-5207609-A Buffered acid-treated food casing VISKASE CORPORATION (US) 1993-05-04 US disclosed
US-5207608-A Buffered acid-treated food casing VISKASE CORPORATION (US) 1993-05-04 US disclosed
US-5108804-A Cellulosic; denatured outer skin with bloom; high speed peeling after chilling; encased raw pork-containing product; distortion resistance VISKASE CORPORATION (US) 1992-04-28 US disclosed